The quality of the reported sample size calculation in clinical trials on COVID-19 patients indexed in PubMed.
作者信息
Lee Paul H
机构信息
School of Nursing, Hong Kong Polytechnic University.
出版信息
Eur J Intern Med. 2020 Jul;77:139-140. doi: 10.1016/j.ejim.2020.04.057. Epub 2020 Apr 30.
Abstract
摘要
相似文献
1
The quality of the reported sample size calculation in clinical trials on COVID-19 patients indexed in PubMed.在PubMed上索引的关于COVID-19患者的临床试验中报告的样本量计算质量。
Eur J Intern Med. 2020 Jul;77:139-140. doi: 10.1016/j.ejim.2020.04.057. Epub 2020 Apr 30.
2
Sample sizes in COVID-19-related research.新冠疫情相关研究中的样本量。
CMAJ. 2020 Apr 27;192(17):E461. doi: 10.1503/cmaj.75308.
3
Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend?皮质类固醇在SARS-CoV-2感染中的应用：是敌，还是能成为友？
Pol Arch Intern Med. 2020 Oct 29;130(10):922. doi: 10.20452/pamw.15661.
4
[Glucocorticoid for coronavirus disease 2019: a dilemma].[2019冠状病毒病的糖皮质激素治疗：一个两难困境]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):278. doi: 10.3760/cma.j.cn121430-20200309-00352.
5
Glucocorticoids save lives in COVID-19 patients.糖皮质激素可拯救 COVID-19 患者的生命。
Int J Biol Sci. 2020 Jul 7;16(13):2477-2478. doi: 10.7150/ijbs.49125. eCollection 2020.
6
Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend? Authors' reply.SARS-CoV-2感染中皮质类固醇的使用：是敌，还是能成为友？作者回复
Pol Arch Intern Med. 2020 Oct 29;130(10):922-923. doi: 10.20452/pamw.15662.
7
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病（NO COVID-19）实用开放性标签研究，评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
8
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19.高血糖、糖皮质激素治疗与新型冠状病毒肺炎的预后
Diabetes Res Clin Pract. 2020 Oct;168:108449. doi: 10.1016/j.diabres.2020.108449. Epub 2020 Sep 17.
9
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.用恢复期血浆治疗 COVID-19：从过去的冠状病毒爆发中吸取的教训。
Clin Microbiol Infect. 2020 Oct;26(10):1436-1446. doi: 10.1016/j.cmi.2020.08.005. Epub 2020 Aug 11.
10
Knowledge is coming so fast that a meta-analysis of COVID-19 treatment is always too late.知识来得如此之快，以至于对新冠病毒肺炎治疗的荟萃分析总是为时已晚。
Pol Arch Intern Med. 2020 Sep 30;130(9):721-723. doi: 10.20452/pamw.15627.
引用本文的文献
1
Diagnostic accuracy of non-invasive SARS-CoV-2 screening tests: a national prospective analysis.新型冠状病毒2型（SARS-CoV-2）非侵入性筛查试验的诊断准确性：一项全国性前瞻性分析。
BMC Infect Dis. 2025 May 21;25(1):727. doi: 10.1186/s12879-025-11088-x.
2
Examining efficacy and safety of ethyl acetate extract from as complementary therapy in COVID-19: A randomized, multicenter, controlled clinical trial.考察[具体植物名称]乙酸乙酯提取物作为COVID-19辅助疗法的疗效和安全性：一项随机、多中心、对照临床试验。 （注：原文中“as complementary therapy in COVID-19”前缺少具体植物名称，翻译时添加了[具体植物名称]以保证句子完整通顺）
Avicenna J Phytomed. 2024 Nov-Dec;14(6):699-710. doi: 10.22038/AJP.2024.24523.
3
Reporting of statistical sample size calculations in publications of trials on age-related macular degeneration, glaucoma and cataract.报告年龄相关性黄斑变性、青光眼和白内障临床试验中统计样本量计算的出版物。
PLoS One. 2021 Jun 4;16(6):e0252640. doi: 10.1371/journal.pone.0252640. eCollection 2021.
4
Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials.针对介入性 COVID-19 临床试验的临床数据驱动的入选标准优化。
J Am Med Inform Assoc. 2021 Jan 15;28(1):14-22. doi: 10.1093/jamia/ocaa276.
本文引用的文献
1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
2
High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial.高流量鼻导管给氧辅助纤维支气管镜引导气管插管用于新型冠状病毒肺炎危重症患者：一项前瞻性随机对照试验
Br J Anaesth. 2020 Jul;125(1):e166-e168. doi: 10.1016/j.bja.2020.02.020. Epub 2020 Mar 20.
3
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
4
Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial.糖皮质激素治疗重症 2019 冠状病毒病患者的有效性：一项随机对照试验方案。
Chin Med J (Engl). 2020 May 5;133(9):1080-1086. doi: 10.1097/CM9.0000000000000791.
5
Clinical trial analysis of 2019-nCoV therapy registered in China.中国注册的 2019-nCoV 疗法的临床试验分析。
J Med Virol. 2020 Jun;92(6):540-545. doi: 10.1002/jmv.25733. Epub 2020 Mar 5.
6
Diagnosis checking of statistical analysis in RCTs indexed in PubMed.在 PubMed 中检索的 RCT 中统计分析的诊断检查。
Eur J Clin Invest. 2017 Nov;47(11):847-852. doi: 10.1111/eci.12833. Epub 2017 Sep 18.
7
A simple approximation for calculating sample sizes for comparing independent proportions.一种用于计算比较独立比例时样本量的简单近似方法。
Biometrics. 1980 Jun;36(2):343-6.
8
Being 'underpowered' does not make a study unethical.研究“样本量不足”并不意味着该研究不道德。
Stat Med. 2012 Dec 20;31(29):4138-9; author reply 4140-1. doi: 10.1002/sim.5451. Epub 2012 Jul 5.
9
Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed.开发一种使用PubMed检索对照试验报告的高灵敏度检索策略。
Int J Epidemiol. 2002 Feb;31(1):150-3. doi: 10.1093/ije/31.1.150.
10
Approaches to sample size estimation in the design of clinical trials--a review.临床试验设计中样本量估计的方法——综述
Stat Med. 1984 Jul-Sep;3(3):199-214. doi: 10.1002/sim.4780030302.
Zotero 插件